Cargando…
Rituximab-Containing Treatment Regimens May Imply a Long-Term Risk for Difficult-To-Treat Chronic Hepatitis E
Hepatitis E virus (HEV) infection is an emerging disease in industrialized countries which is usually characterized by a self-limited course. However, there is an increased risk of HEV persistence in immunocompromised risk populations, comprising patients following solid organ transplantation or hem...
Autores principales: | Schulz, Marten, Biedermann, Paula, Bock, Claus-Thomas, Hofmann, Jörg, Choi, Mira, Tacke, Frank, Hanitsch, Leif Gunnar, Mueller, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982013/ https://www.ncbi.nlm.nih.gov/pubmed/31947836 http://dx.doi.org/10.3390/ijerph17010341 |
Ejemplares similares
-
Editorial: SARS-COV-2 infections within inborn errors of immunity populations
por: Hanitsch, Leif Gunnar, et al.
Publicado: (2023) -
Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group
por: Than, Nwe Ni, et al.
Publicado: (2019) -
The role of gender in patients with diffuse large B cell lymphoma treated with rituximab-containing regimens: a meta-analysis
por: Yıldırım, Mustafa, et al.
Publicado: (2015) -
Identifying High-Risk NASH Patients: What We Know so Far
por: Schulz, Marten, et al.
Publicado: (2020) -
Prophylaktisches und therapeutisches Management erhöhter Infektionsanfälligkeit bei Immundefekten
por: Hanitsch, Leif G.
Publicado: (2022)